Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Healthtrust
Covington
Accenture
Dow
UBS
Farmers Insurance
Baxter
Chubb
Daiichi Sankyo

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: RE43580

« Back to Dashboard

Which drugs does patent RE43580 protect, and when does it expire?

Patent RE43580 protects FORTICAL and is included in one NDA.

This patent has seven patent family members in five countries.
Summary for Patent: RE43580
Title:Nasal calcitonin formulations
Abstract: .[.A liquid pharmaceutical composition is disclosed comprising calcitonin or an acid addition salt thereof and citric acid or salt thereof in a concentration from about to about 50 mM, said composition being in a form table for nasal administration..]. .Iadd.A liquid pharmaceutical composition is provided for nasal administration of calcitonin or an acid addition salt thereof. The nasal pharmaceutical formulations contain a component selected from the group consisting of citric acid, citric acid salt and a combination thereof. .Iaddend.
Inventor(s): Stern; William (Tenafly, NJ)
Assignee: Unigene Laboratories, Inc. (Boonton, NJ)
Application Number:12/459,385
Patent Claim Types:
see list of patent claims
Composition; Use; Delivery;

Drugs Protected by US Patent RE43580

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Upsher-smith Labs FORTICAL calcitonin salmon recombinant SPRAY, METERED;NASAL 021406-001 Aug 12, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y NASAL ADMINISTRATION ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent RE43580

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,440,392 Nasal calcitonin formulations ➤ Try a Free Trial
RE40812 Nasal calcitonin formulation ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent RE43580

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 0156594 ➤ Try a Free Trial
European Patent Office 1251867 ➤ Try a Free Trial
China 1183965 ➤ Try a Free Trial
China 1422160 ➤ Try a Free Trial
Canada 2399505 ➤ Try a Free Trial
Australia 783952 ➤ Try a Free Trial
Australia 3660401 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fish and Richardson
Baxter
Daiichi Sankyo
McKinsey
Boehringer Ingelheim
AstraZeneca
Cantor Fitzgerald
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot